Literature DB >> 8377926

Transvenous embolization of dural caroticocavernous fistulae: technical considerations.

K Yamashita1, W Taki, S Nishi, A Sadato, I Nakahara, H Kikuchi, Y Yonekawa.   

Abstract

Sixteen patients with symptomatic dural caroticocavernous fistulae were treated by transvenous embolization, via the jugular vein and inferior petrosal sinus. The fistula was occluded by thrombogenic coils. Complete resolution of symptoms and signs was achieved in 14 patients, and complete angiographic resolution was also obtained in 14 patients. Failures to achieve angiographic cure were attributed to failure to reach the fistula within the cavernous sinus precisely. Factors which make placement of the catheter at the fistula difficult are trabeculae within the cavernous sinus, a specific configuration of the superior ophthalmic vein and venous thrombosis. To improve the efficacy of transvenous embolization, every possible venous route to the cavernous sinus therefore should be tried, to facilitate reaching the fistula and the possibility of transvenous embolization should not be thwarted by venous thrombosis.

Entities:  

Mesh:

Year:  1993        PMID: 8377926     DOI: 10.1007/bf00602836

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  23 in total

1.  Treatment of dural carotid-cavernous fistulas via the superior ophthalmic vein.

Authors:  L H Monsein; G M Debrun; N R Miller; H J Nauta; J R Chazaly
Journal:  AJNR Am J Neuroradiol       Date:  1991 May-Jun       Impact factor: 3.825

2.  The "cavernous" sinus.

Authors:  M A Bedford
Journal:  Br J Ophthalmol       Date:  1966-01       Impact factor: 4.638

3.  Orbital venography.

Authors:  W N Hanafee; P C Shiu; G O Dayton
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-09

4.  Cavernous sinus venography.

Authors:  P C Shiu; W N Hanafee; G H Wilson; R W Rand
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-09

5.  Intracavernous aneurysms and carotid-cavernous fistulas. A clinicopathological study.

Authors:  H Miyazaki; M Kurihara; H Ishizaka; M Kawano; K Mori
Journal:  Neurol Med Chir (Tokyo)       Date:  1981-01       Impact factor: 1.742

6.  Occlusion of arteriovenous malformations of the cavernous sinus via the superior ophthalmic vein.

Authors:  M M Teng; W Y Guo; C I Huang; C C Wu; T Chang
Journal:  AJNR Am J Neuroradiol       Date:  1988 May-Jun       Impact factor: 3.825

7.  [The orbital phlebogram].

Authors:  G Offret; D Aron-Rosa; J Metzger; D Doyon
Journal:  Acta Radiol Diagn (Stockh)       Date:  1966

8.  Management of spontaneous carotid-cavernous fistulae.

Authors:  M Ishikawa; H Handa; W Taki; S Yoneda
Journal:  Surg Neurol       Date:  1982-08

9.  Spontaneous carotid-cavernous fistulas: clinical, radiological, and therapeutic considerations. Experience with 20 cases.

Authors:  F Viñuela; A J Fox; G M Debrun; S J Peerless; C G Drake
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

10.  Neurological manifestations of intracranial dural arteriovenous malformations.

Authors:  P Lasjaunias; M Chiu; K ter Brugge; A Tolia; M Hurth; M Bernstein
Journal:  J Neurosurg       Date:  1986-05       Impact factor: 5.115

View more
  21 in total

1.  Transsphenoidal computer-navigation-assisted deflation of a balloon after endovascular occlusion of a direct carotid cavernous sinus fistula.

Authors:  J Klisch; J Schipper; H Husstedt; R Laszig; M Schumacher
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

2.  Endovascular management of dural carotid-cavernous sinus fistulas in 141 patients.

Authors:  M Kirsch; H Henkes; T Liebig; W Weber; J Esser; S Golik; D Kühne
Journal:  Neuroradiology       Date:  2006-04-26       Impact factor: 2.804

3.  Targeted compartmental embolization of cavernous sinus dural arteriovenous fistulae using transfemoral medial and lateral facial vein approaches.

Authors:  R Agid; R A Willinsky; C Haw; M P S Souza; I J Vanek; K G terBrugge
Journal:  Neuroradiology       Date:  2003-12-04       Impact factor: 2.804

4.  Superior petrosal sinus catheterization for transvenous embolization of a dural carotid cavernous sinus fistula.

Authors:  Charbel Mounayer; Michel Piotin; Laurent Spelle; Jacques Moret
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

5.  Facial vein catheterization for transvenous embolization of the cavernous sinus. Technique and advantages of the direct jugular vein approach - report of three cases.

Authors:  M N Karygiannis; Z Szatmary; P A Claudino; E Houdart
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

6.  A venographic operational classification for transvenous embolization of dural carotid-cavernous fistula.

Authors:  Simon C H Yu; K M Cheng; Patrick H T Tam; George K C Wong; C M Chan; Y L Cheung; W S Poon
Journal:  Neuroradiology       Date:  2010-12-23       Impact factor: 2.804

7.  Transvenous n-butyl-cyanoacrylate infusion for complex dural carotid cavernous fistulas: technical considerations and clinical outcome.

Authors:  Ajay K Wakhloo; Alain Perlow; Italo Linfante; Johnny S Sandhu; John Cameron; Neil Troffkin; Alexander Schenck; Norman J Schatz; David T Tse; Byron L Lam
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

8.  [Interdisciplinary treatment of carotid cavernous fistulas via the superior ophthalmic vein].

Authors:  C Kuettner; F Goetz; F-J Kramer; P Brachvogel
Journal:  Mund Kiefer Gesichtschir       Date:  2006-01

9.  Triple coaxial catheter technique for transfacial superior ophthalmic vein approach for embolization of dural carotid-cavernous fistula.

Authors:  M-H Yuen; K-M Cheng; Y-L Cheung; C-M Chan; S C H Yu; G K C Wong; W-S Poon
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

10.  Blind endovascular catheterization and direct access of an occluded superior ophthalmic vein for treatment of carotid cavernous fistula.

Authors:  Ali Alaraj; Bobby Kim; Gerald Oh; Victor Aletich
Journal:  BMJ Case Rep       Date:  2013-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.